Your browser doesn't support javascript.
loading
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study.
Aardema, Heleen; Nannan Panday, Prashant; Wessels, Mireille; van Hateren, Kay; Dieperink, Willem; Kosterink, Jos G W; Alffenaar, Jan-Willem; Zijlstra, Jan G.
Afiliación
  • Aardema H; Department of Critical Care, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: h.aardema@umcg.nl.
  • Nannan Panday P; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Wessels M; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • van Hateren K; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Dieperink W; Department of Critical Care, University Medical Center Groningen, Groningen, The Netherlands.
  • Kosterink JGW; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Section of Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University Medical Center Groningen, University of Groningen, Groningen, The Netherl
  • Alffenaar JW; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Zijlstra JG; Department of Critical Care, University Medical Center Groningen, Groningen, The Netherlands.
Int J Antimicrob Agents ; 50(1): 68-73, 2017 Jul.
Article en En | MEDLINE | ID: mdl-28501674
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Crítica / Ácido Penicilánico / Inhibidores de beta-Lactamasas / Antibacterianos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Antimicrob Agents Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Crítica / Ácido Penicilánico / Inhibidores de beta-Lactamasas / Antibacterianos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Antimicrob Agents Año: 2017 Tipo del documento: Article